Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannaPatch is a biotechnology company focused on the development of advanced transdermal delivery systems for cannabinoids. Utilizing proprietary technology developed by Prof. Elka Touitou at the Hebrew University of Jerusalem, the company creates patches that allow for the controlled, sustained release of medical cannabis components like THC and CBD through the skin. This method aims to provide systemic relief for conditions such as chronic pain and inflammation while avoiding the side effects associated with smoking or ingestion. The company's products are designed to improve patient compliance and therapeutic outcomes in the medical cannabis sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canna Patch.